Search Within

Alfredo Rivas Delgado

Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Center for Hematologic Malignancies (19)
  4. Lymphoma (19)
  5. GME, Medicine (16)
  6. Graduate Medical Education (16)

More Groups

People
  1. Gilles Salles (19)
  2. Maria Palomba (19)
  3. Efrat Luttwak (15)
  4. Jennifer Lue (11)
  5. Lorenzo Falchi (11)
  6. Magdalena Corona De Lapuerta (11)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (5)
Publications
  1. Blood (12)
  2. Blood Cancer Journal (2)
  3. Haematologica (2)
  4. Blood Advances (1)
  5. Blood Cancer Discovery (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Ferrata Storti Foundation (2)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. John Wiley & Sons (1)
  6. Landes Bioscience (1)

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR-tography: Longitudinal mapping of CAR-T toxicities across B-cell malignancies reveals biologically distinct and prognostically relevant toxicity phenotypes
    Meeting Abstract

    Rejeski, K.; Fei, T.; Luna, A.; Alhomoud, M.; Valtis, Y. K.; Nishimura, N.; Gomez-Llobell, M.; Accav, N. G.; Beyar-Katz, O.; Raj, S. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The landscape of T-cell engagers for the treatment of follicular lymphoma
    Review

    Rivas-Delgado, A.; Landego, I.; Falchi, L.
    OncoImmunology (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: Real-world experience from a cancer center
    Research Letter

    Zhu, M. L.; Drill, E.; Joffe, E.; Salles, G.; Rivas Delgado, A.; Zelenetz, A.; Palomba, M. L.; Arcila, M.; Dogan, A.
    Haematologica (2024)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save